[18F]Amylovis

N/A

Report date: 2025/11/10 17:58:33

NME

Base Information

Drug Name[18F]Amylovis

Drug Alias NameN/A

ClassificationRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionBeta amyloid A4 protein inhibitors

TargetsBeta amyloid A4 protein

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCuba

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCenter For Neurosciences

China Registration ClassN/A

Develop Information

Active CompaniesCenter For Neurosciences

Inactive CompaniesN/A

Active IndicationsAlzheimer Disease

Inactive IndicationsN/A

Other Information

ATC CodeN/A